Search alternatives:
significant source » significant burden (Expand Search)
side decrease » sizes decrease (Expand Search), fid decreased (Expand Search), step decrease (Expand Search)
significant source » significant burden (Expand Search)
side decrease » sizes decrease (Expand Search), fid decreased (Expand Search), step decrease (Expand Search)
-
261
-
262
-
263
-
264
Summary of post-treatment disease course measures from off-label medications clinical trials.
Published 2025Subjects: -
265
Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.
Published 2025Subjects: -
266
Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.
Published 2025Subjects: -
267
Summary of post-treatment disease course measures from clinical trials with psychotherapies.
Published 2025Subjects: -
268
-
269
-
270
Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.
Published 2025Subjects: -
271
-
272
-
273
-
274
-
275
-
276
B2 decreases glycolytic intermediates in cells.
Published 2025“…Other abbreviations: HGA, DL-hydroxyglutaric acid; PEP, phosphoenolpyruvic acid; 3-PGA, 3-phosphoglyceric acid; G3P; glyceraldehyde 3-phosphate; Data (n = 5) are shown as mean±SD. Not significant (ns): **<i>P</i> ≤ 0.01, ****<i>P</i> ≤ 0.0001by one-way ANOVA with multiple comparison of the mean of each test group to the mean of the vehicle control. …”
-
277
-
278
-
279
-
280